GlassScriptPhysician profile
David T Taylor
NPI 1447251475
$16,150.44
in general payments reported to CMS, 2019-2025
45 companies · $2,671 in 2025
The $2,671 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,888 · 2020: $1,233 · 2021: $1,239 · 2022: $2,178 · 2023: $4,512 · 2024: $2,430 · 2025: $2,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,612.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenacare Global, LLC | $3,157.54 | 2023-2024 | |
| Smith+Nephew, INC. | $2,725.01 | 2019-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Stryker Corporation | $1,555.45 | 2022-2025 | Ortholoc 2 Lapifuse, Ortholoc 3di, Augment Injectable |
| Horizon Therapeutics Plc | $1,335.11 | 2019-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $859.21 | 2019-2025 | N/A, Na, Hammerlock |
| Bioventus LLC | $769.63 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Stimrouter Implantable Kit |
| Paragon 28, INC. | $691.77 | 2019-2025 | Portfolio, Ttc Nail, Bun-Yo-Matic |
| Paratek Pharmaceuticals, INC. | $465.63 | 2021-2025 | Nuzyra |
| Kerecis Limited | $459.44 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Cardiovascular Systems INC. | $451.33 | 2019-2022 | |
| Melinta Therapeutics, LLC | $438.20 | 2019-2023 | Kimyrsa |
| Wright Medical Technology, INC. | $308.21 | 2019-2020 | |
| Osteomed LLC | $284.64 | 2020-2022 | |
| Abbvie INC. | $284.12 | 2022-2025 | Dalvance |
| Treace Medical Concepts, INC. | $220.55 | 2022-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $194.41 | 2024-2025 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $174.61 | 2020-2022 | |
| Nevro Corp. | $170.89 | 2023 | Senza |
| Organogenesis INC. | $153.06 | 2019-2022 | |
| Mimedx Group, INC. | $142.94 | 2024-2025 | |
| Integra Lifesciences Corporation | $142.05 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Reflow Medical INC | $130.49 | 2024-2025 | |
| Cordis US Corp. | $125.00 | 2022 | |
| Alafair Biosciences, INC. | $106.77 | 2025 | Versawrap |
| Aroa Biosurgery Incorporated | $106.56 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $102.41 | 2019 | |
| Medline Industries LP | $97.07 | 2022 | |
| Acera Surgical, INC. | $94.00 | 2023 | Restrata Wound Matrix |
| Medtronic Vascular, INC. | $47.24 | 2019 | |
| Surgenex LLC | $42.98 | 2025 | Renograft, Ardeograft, Surmatrix |
| Pfizer INC. | $36.80 | 2019 | |
| Alfasigma USA, INC. | $31.59 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $27.15 | 2025 | |
| Cashflow Solutions, LLC | $24.39 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Zyla Life Sciences, INC. | $23.89 | 2019 | |
| Bard Peripheral Vascular, INC. | $23.38 | 2021 | |
| Anika Therapeutics, INC. | $21.48 | 2021 | |
| Trice Medical, INC. | $19.54 | 2025 | |
| Heron Therapeutics, INC. | $19.39 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.09 | 2021 | |
| Kci USA, INC. | $16.23 | 2019 | |
| Omeza LLC | $14.72 | 2024 | |
| Acacia Pharma INC | $13.73 | 2021 | |
| Medtronic, INC. | $13.16 | 2023 | Endurant Iis |
| Orthofix Medical, INC. | $10.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.